XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Revision of Prior Period, Adjustment [Member]
Newly Stated [Member]
 [1]
Common Stock
Common Stock
Revision of Prior Period, Adjustment [Member]
Common Stock
Newly Stated [Member]
 [1]
Additional Paid-In Capital
Additional Paid-In Capital
Revision of Prior Period, Adjustment [Member]
Additional Paid-In Capital
Newly Stated [Member]
 [1]
Accumulated Other Comprehensive Gain (Loss)
Accumulated Other Comprehensive Gain (Loss)
Newly Stated [Member]
 [1]
Accumulated Deficit
Accumulated Deficit
Newly Stated [Member]
 [1]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Revision of Prior Period, Adjustment [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Newly Stated [Member]
 [1]
Beginning balance at Dec. 31, 2020 $ (32,256)   $ (32,256)   $ 2 $ 2 $ 133,144 $ (2) $ 133,142 $ 5 $ 5 $ (165,405) $ (165,405) $ 81,523   $ 81,523
Beginning balance, shares at Dec. 31, 2020       20,975,317 (4,467,972) 16,507,345               98,726,505 (21,029,826) 77,696,679
Issuance of common stock upon exercise of stock options 26           26                  
Issuance of common stock upon exercise of stock options, shares       118,566                        
Stock-Based Compensation 597           597                  
Foreign currency translation gain (loss) 52                 52            
Net loss (7,787)                     (7,787)        
Ending balance at Mar. 31, 2021 (39,368)     $ 2     133,765     57   (173,192)   $ 81,523    
Ending balance, shares at Mar. 31, 2021       16,625,911                   77,696,679    
Beginning balance at Dec. 31, 2020 (32,256)   (32,256)   $ 2 $ 2 133,144 (2) 133,142 5 5 (165,405) (165,405) $ 81,523   $ 81,523
Beginning balance, shares at Dec. 31, 2020       20,975,317 (4,467,972) 16,507,345               98,726,505 (21,029,826) 77,696,679
Foreign currency translation gain (loss) 50                              
Net loss (17,861)                              
Ending balance at Jun. 30, 2021 (48,832)     $ 2     134,377     55   (183,266)   $ 81,523    
Ending balance, shares at Jun. 30, 2021       17,076,119                   77,696,679    
Beginning balance at Mar. 31, 2021 (39,368)     $ 2     133,765     57   (173,192)   $ 81,523    
Beginning balance, shares at Mar. 31, 2021       16,625,911                   77,696,679    
Issuance of common stock upon exercise of stock options 90           90                  
Issuance of common stock upon exercise of stock options, shares       338,979                        
Issuance of common stock upon exercise of common stock warrants (Share)       111,229                        
Issuance of common stock upon exercise of common stock warrants 1           1                  
Stock-Based Compensation 521           521                  
Foreign currency translation gain (loss) (2)                 (2)            
Net loss (10,074)                     (10,074)        
Ending balance at Jun. 30, 2021 (48,832)     $ 2     134,377     55   (183,266)   $ 81,523    
Ending balance, shares at Jun. 30, 2021       17,076,119                   77,696,679    
Beginning balance at Dec. 31, 2021 (71,528) [2]   (71,528) [2]   $ 2 $ 2 135,551 [2] (2) [2] 135,549 [2] 52 52 (207,131) [2] (207,131) [2] $ 81,523   $ 81,523
Beginning balance, shares at Dec. 31, 2021       23,153,127 (4,932,058) 18,221,069               98,726,505 (21,029,826) 77,696,679
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination 81,523 [2]     $ 6     81,517 [2]             $ (81,523)    
Issuance of common stock upon exercise of stock options [2] 574           574                  
Issuance of common stock upon exercise of stock options, shares       1,123,539                        
Issuance of common stock upon exercise of legacy Rigetti common stock warrants [2] 28           28                  
Issuance of common stock upon exercise of legacy Rigetti common stock warrants, shares       2,234,408                        
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination, shares       57,380,563                   (77,696,679)    
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities [2] 159,538     $ 3     159,535                  
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, shares [2]       34,850,706                        
Stock-Based Compensation [2] 11,481           11,481                  
Foreign currency translation gain (loss) 9 [2]                 9            
Net loss [2] (17,642)                     (17,642)        
Ending balance at Mar. 31, 2022 163,983 [2]     $ 11     388,684 [2]     61   (224,773) [2]   $ 0    
Ending balance, shares at Mar. 31, 2022       113,810,285                   0    
Beginning balance at Dec. 31, 2021 $ (71,528) [2]   $ (71,528) [2]   $ 2 $ 2 135,551 [2] $ (2) [2] $ 135,549 [2] 52 $ 52 (207,131) [2] $ (207,131) [2] $ 81,523   $ 81,523
Beginning balance, shares at Dec. 31, 2021       23,153,127 (4,932,058) 18,221,069               98,726,505 (21,029,826) 77,696,679
Issuance of common stock upon exercise of stock options, shares 1,353,145                              
Foreign currency translation gain (loss) [2] $ 47                              
Net loss (29,894) [2] $ (9,450)                            
Ending balance at Jun. 30, 2022 $ 170,100 [2] (3,725)   $ 11     407,015 [2]     99   (237,025) [2]   $ 0    
Ending balance, shares at Jun. 30, 2022 113,810,285     117,102,735                   0    
Beginning balance at Mar. 31, 2022 $ 163,983 [2]     $ 11     388,684 [2]     61   (224,773) [2]   $ 0    
Beginning balance, shares at Mar. 31, 2022       113,810,285                   0    
Issuance of common stock upon exercise of stock options [2] 62           62                  
Issuance of common stock upon exercise of stock options, shares       229,606                        
Issuance of common stock upon release of RSUs (Share)       1,360,634                        
Issuance of common stock upon exercise of common stock warrants (Share)       1,702,210                        
Issuance of common stock upon exercise of common stock warrants [2] 5,011           5,011                  
Reclassification of loan and security agreement warrants to equity [2] 6,370           6,370                  
Settlement of the first tranche of forward contract [2] (3,305)           (3,305)                  
Capitalization of deferred costs to equity upon share issuance [2] (848)           (848)                  
Stock-Based Compensation [2] 11,041           11,041                  
Foreign currency translation gain (loss) 38 [2]                 38            
Net loss (12,252) [2] (2,278)                   (12,252) [2]        
Ending balance at Jun. 30, 2022 $ 170,100 [2] $ (3,725)   $ 11     $ 407,015 [2]     $ 99   $ (237,025) [2]   $ 0    
Ending balance, shares at Jun. 30, 2022 113,810,285     117,102,735                   0    
[1] Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A common stock, and legacy Class B common stock have been retroactively restated to give effect to the Business Combination.
[2] For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors